Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorZiekenhuis Oost-Limburg

About this trial

During direct anterior approach (DAA) for total hip arthroplasty (THA), ligation of the lateral femoral circumflex artery and vessel is always conducted. However, this standardized procedure may jeopardize blood muscle perfusion and cause tenderness in the tensor fascia lata muscle. The investigators want to investigate whether blood vessel-sparing surgery is feasible, reproducible, and would alter outcomes following DAA THA.

The surgical technique of the vessel-sparing procedure will be described and investigated in a prospective blinded RCT. The investigators hypothesize that the vessel-sparing technique is feasible in 60% of the patients. If these vessels were not sacrificed, the investigators expect the incidence of TFL tendinopathy to be lower.

Eligibility criteria

Qualifiers

Scheduled for THA by Dr. Frans-Jozef Vandeputte or Professor Dr. Kristoff Corten

Provide signed and dated informed consent

Males or females age > 18 years

Disqualifiers

Neurological problems with sensorial and/or motoric disturbances (Multiple Sclerosis, Parkinson's disease, hemiplegia, …)

Previous surgery of the ipsilateral hip

Ipsilateral neck of femur fracture

Previous contralateral THA

Trial design

Treatments tested in this trial

  • Vessel sparing technique
  • Vessel ligation technique

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators